Impact of PCV on Disease and Colonization Among Native American Communities

NCT01083459 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6628

Last updated 2015-01-19

No results posted yet for this study

Summary

The purpose of this study is to determine the impact of pneumococcal conjugate vaccine on carriage of pneumococcus in the nasopharynx and on the incidence of invasive pneumococcal disease in the community.

Conditions

  • Pneumococcal Nasopharyngeal Colonization
  • Invasive Pneumococcal Disease

Sponsors & Collaborators

Principal Investigators

  • Katherine L O'Brien, MD · Johns Hopkins Bloomberg School of Public Health

  • Lindsay R Grant, PhD · Johns Hopkins Bloomberg School of Public Health

Eligibility

Min Age
7 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01083459 on ClinicalTrials.gov